108 related articles for article (PubMed ID: 32837100)
1. An ayurvedic perspective along with in silico study of the drugs for the management of SARS-CoV-2.
Gandhi AJ; Rupareliya JD; Shukla VJ; Donga SB; Acharya R
J Ayurveda Integr Med; 2022; 13(1):100343. PubMed ID: 32837100
[TBL] [Abstract][Full Text] [Related]
2. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
3. In Silico Screening for Anti-inflammatory Bioactive Molecules from Ayurvedic Decoction, Balaguluchyadi kashayam.
S J RD; Kumar B P
Curr Comput Aided Drug Des; 2020; 16(4):435-450. PubMed ID: 31749431
[TBL] [Abstract][Full Text] [Related]
4. Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation.
Gorla US; Rao K; Kulandaivelu US; Alavala RR; Panda SP
Comb Chem High Throughput Screen; 2021; 24(6):879-890. PubMed ID: 32819226
[TBL] [Abstract][Full Text] [Related]
5. Ayurvedic formulations: Potential COVID-19 therapeutics?
Mahaboob Ali AA; Bugarcic A; Naumovski N; Ghildyal R
Phytomed Plus; 2022 Aug; 2(3):100286. PubMed ID: 35474908
[TBL] [Abstract][Full Text] [Related]
6. Structure-based docking, pharmacokinetic evaluation, and molecular dynamics-guided evaluation of traditional formulation against SARS-CoV-2 spike protein receptor bind domain and ACE2 receptor complex.
Kumar BH; Manandhar S; Mehta CH; Nayak UY; Pai KSR
Chem Zvesti; 2022; 76(2):1063-1083. PubMed ID: 34690412
[TBL] [Abstract][Full Text] [Related]
7.
Ram TS; Munikumar M; Raju VN; Devaraj P; Boiroju NK; Hemalatha R; Prasad PVV; Gundeti M; Sisodia BS; Pawar S; Prasad GP; Chincholikar M; Goel S; Mangal A; Gaidhani S; Srikanth N; Dhiman KS
J Ayurveda Integr Med; 2022; 13(1):100413. PubMed ID: 33654345
[TBL] [Abstract][Full Text] [Related]
8. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Some Antiviral Natural Products to Fight Against Novel Coronavirus (SARS-CoV-2) Using an
Shah A; Patel V; Parmar B
Comb Chem High Throughput Screen; 2021; 24(8):1271-1280. PubMed ID: 32881661
[TBL] [Abstract][Full Text] [Related]
10. Virtual screening, ADME/T, and binding free energy analysis of anti-viral, anti-protease, and anti-infectious compounds against NSP10/NSP16 methyltransferase and main protease of SARS CoV-2.
Maurya SK; Maurya AK; Mishra N; Siddique HR
J Recept Signal Transduct Res; 2020 Dec; 40(6):605-612. PubMed ID: 32476594
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel coumarin analogues: Investigation of molecular docking interaction of SARS-CoV-2 proteins with natural and synthetic coumarin analogues and their pharmacokinetics studies.
Chidambaram S; El-Sheikh MA; Alfarhan AH; Radhakrishnan S; Akbar I
Saudi J Biol Sci; 2021 Jan; 28(1):1100-1108. PubMed ID: 33199969
[TBL] [Abstract][Full Text] [Related]
12.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
13. Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor.
Maurya VK; Kumar S; Prasad AK; Bhatt MLB; Saxena SK
Virusdisease; 2020 Jun; 31(2):179-193. PubMed ID: 32656311
[TBL] [Abstract][Full Text] [Related]
14. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic insights from the review and evaluation of ayurvedic herbal medicines for the prevention and management of COVID-19 patients.
Sarkar PK; Das Mukhopadhyay C
J Herb Med; 2022 Mar; 32():100554. PubMed ID: 35251909
[TBL] [Abstract][Full Text] [Related]
16. Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening.
Abdusalam AAA; Murugaiyah V
Front Mol Biosci; 2020; 7():603037. PubMed ID: 33392261
[TBL] [Abstract][Full Text] [Related]
17. Compounds of
Haridas M; Sasidhar V; Nath P; Abhithaj J; Sabu A; Rammanohar P
Futur J Pharm Sci; 2021; 7(1):13. PubMed ID: 33457429
[TBL] [Abstract][Full Text] [Related]
18. Molecular Docking and ADMET Prediction of Natural Compounds towards SARS Spike Glycoprotein-Human Angiotensin-Converting Enzyme 2 and SARS-CoV-2 Main Protease.
Oso BJ; Olaoye IF; Omeike SO
Arch Razi Inst; 2021; 76(3):453-459. PubMed ID: 34824739
[TBL] [Abstract][Full Text] [Related]
19. Exploring the active compounds of traditional Mongolian medicine in intervention of novel coronavirus (COVID-19) based on molecular docking method.
Yu JW; Wang L; Bao LD
J Funct Foods; 2020 Aug; 71():104016. PubMed ID: 32421102
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
